This is the first post on the Traqr Blog. It exists for two reasons: to give us a public place to write plain-language guides for GLP-1 therapy, and to exercise the new editorial template before any clinical content ships.
This post is not clinical. It does not describe medications, dosages, side effects, or treatment decisions, and it is reviewed under our editorial standards rather than by a clinician. Every article that touches medication or medical guidance is reviewed by a credentialed clinician before publication — look for the Medically reviewed by line at the top of those posts.
What you can expect
Over the next few months we’ll publish guides on:
- Getting started with GLP-1 therapy — what the first weeks feel like, how to track progress without obsessing, when to call your doctor.
- Side effects — what’s normal, what’s a red flag, and the practical tricks people use to manage nausea, fatigue, and constipation.
- Insurance and cost — Medicaid, Medicare, manufacturer copay programs, and prior auth in plain language.
- Nutrition — protein targets, hydration, and meal timing while appetite is suppressed.
How we review posts
Every clinical post lists the clinician who reviewed it and the date of that review1. If the last review is more than 12 months old, we show an out-of-date banner at the top of the article. Editorial posts (like this one) are reviewed by our editorial standards team and clearly marked as non-clinical.
We also publish a citation list at the bottom of each clinical article, with links to the underlying guideline or study.
Footnotes
-
Posts published before launch use a placeholder reviewer entry that will be replaced with the real clinician’s name and credentials during content migration. ↩
